1. Incobotulinumtoxina (Xeominî) Versus Onabotulinumtoxina (Botoxî): Evaluation of Clinical Onset of Action with Rating Scales and Electroneurography
- Author
-
Riccardo Marvulli, Paolo Trerotoli, E Romanelli, Lucia Mastromauro, and Giancarlo Ianieri
- Subjects
medicine.medical_specialty ,business.industry ,Elbow ,Clinical onset ,Surgery ,Compound muscle action potential ,Muscle tone ,medicine.anatomical_structure ,Rating scale ,Anesthesia ,Electroneuronography ,Medicine ,Onset of action ,Spasticity ,medicine.symptom ,business - Abstract
Onset of action, duration and maximum efficacy of different botulinum toxin type A (BoNT/A) preparations have been compared mainly in in vitro studies. This single-center open study compared onset of action of the two BoNT/A preparations onabotulinumtoxinA (complex size 900 kDa) and incobotulinumtoxinA (free of complexing proteins, 150 kDa) in patients with spasticity after cerebral stroke over a 15-day treatment period. Outcome measures were changes in muscle tone, increase in passive extension of the elbow, changes in limb functionality, and variation of the amplitude of the compound muscle action potential (cMAP) determined by electroneurography. A total of 108 patients (mean age 64.8 ± 11.3 years) were included in the study, 54 in each treatment arm. Muscle tone, elbow motion range, and limb function significantly improved in both groups from baseline to day 15 after BoNT/A injection (p
- Published
- 2015
- Full Text
- View/download PDF